Literature DB >> 10996224

Matrix metalloprotease-9 release from monocytes increases as a function of differentiation: implications for neuroinflammation and neurodegeneration.

C M Vos1, S Gartner, R M Ransohoff, J C McArthur, L Wahl, L Sjulson, E Hunter, K Conant.   

Abstract

Naïve monocytes extravasate in response to monocyte chemoattractant-1 (MCP-1) and subsequently, following differentiation within tissue, carry out effector functions. Consistent with this concept, expression of the MCP-1 receptor CCR2 decreases with monocyte differentiation, as production of cytokines increases (Fantuzzi et al., 1999). Because matrix metalloproteases (MMPs) may also play an important role in the ability of monocytes to migrate into tissues and/or to promote pathogen clearance/tissue injury, we have examined production of matrix metalloprotease-9 as a function of both monocyte differentiation in vitro and expression of CCR2. Increased time in culture, which is linked to monocyte differentiation, resulted in enhanced production of MMP-9, assessed by gelatin substrate zymography. Further, CCR2-negative monocytes produced greater quantities of MMP-9 than did naïve CCR2-positive cells. Our results indicate that MMP-9 release increases during monocyte differentiation, consistent with a prominent role in effector functions. Because extracellular matrix proteins are important to cell structure and survival (Wee Yong et al., 1998), increased expression of MMP-9 could contribute to tissue damage following monocyte differentiation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10996224     DOI: 10.1016/s0165-5728(00)00308-8

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  10 in total

1.  Methamphetamine and HIV-1 gp120 effects on lipopolysaccharide stimulated matrix metalloproteinase-9 production by human monocyte-derived macrophages.

Authors:  Jessica L Reynolds; Supriya D Mahajan; Ravikumar Aalinkeel; Bindukumar Nair; Donald E Sykes; Stanley A Schwartz
Journal:  Immunol Invest       Date:  2011-03-22       Impact factor: 3.657

Review 2.  Circulating glioma biomarkers.

Authors:  Johan M Kros; Dana M Mustafa; Lennard J M Dekker; Peter A E Sillevis Smitt; Theo M Luider; Ping-Pin Zheng
Journal:  Neuro Oncol       Date:  2014-09-24       Impact factor: 12.300

Review 3.  The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis.

Authors:  T E VanMeter; H K Rooprai; M M Kibble; H L Fillmore; W C Broaddus; G J Pilkington
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

4.  Targeted deletion of CC chemokine receptor 2 attenuates left ventricular remodeling after experimental myocardial infarction.

Authors:  Koichi Kaikita; Takanori Hayasaki; Toshiyuki Okuma; William A Kuziel; Hisao Ogawa; Motohiro Takeya
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

5.  Blood-based inflammation biomarkers of neurocognitive impairment in people living with HIV.

Authors:  Naomi Swanta; Subhash Aryal; Vicki Nejtek; Sangeeta Shenoy; Anuja Ghorpade; Kathleen Borgmann
Journal:  J Neurovirol       Date:  2020-03-19       Impact factor: 2.643

6.  Regulation of tissue inhibitor of metalloproteinase-1 by astrocytes: links to HIV-1 dementia.

Authors:  Radhika Suryadevara; Spring Holter; Kathleen Borgmann; Raisa Persidsky; Christine Labenz-Zink; Yuri Persidsky; Howard E Gendelman; Li Wu; Anuja Ghorpade
Journal:  Glia       Date:  2003-10       Impact factor: 7.452

Review 7.  Natural Marine and Terrestrial Compounds as Modulators of Matrix Metalloproteinases-2 (MMP-2) and MMP-9 in Alzheimer's Disease.

Authors:  Lidia Ciccone; Jennifer Vandooren; Susanna Nencetti; Elisabetta Orlandini
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-24

Review 8.  The role of microglia and matrix metalloproteinases involvement in neuroinflammation and gliomas.

Authors:  Helen Könnecke; Ingo Bechmann
Journal:  Clin Dev Immunol       Date:  2013-08-14

Review 9.  Tumor Microenvironment in Glioma Invasion.

Authors:  Sho Tamai; Toshiya Ichinose; Taishi Tsutsui; Shingo Tanaka; Farida Garaeva; Hemragul Sabit; Mitsutoshi Nakada
Journal:  Brain Sci       Date:  2022-04-15

10.  Blood-Based Biomarkers Predictive of Metformin Target Engagement in Fragile X Syndrome.

Authors:  Mittal Jasoliya; Heather Bowling; Ignacio Cortina Petrasic; Blythe Durbin-Johnson; Eric Klann; Aditi Bhattacharya; Randi Hagerman; Flora Tassone
Journal:  Brain Sci       Date:  2020-06-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.